Article
Assessing Survival in Non-Small Cell Lung Cancer Brain Metastases After Stereotactic Radiosurgery: Before and After the Start of the Targetable Mutation Era
2024-04-22
Abstract excerpt
<title>Abstract</title> <p>Purpose Targeted treatment options for non-small cell lung cancer (NSCLC) brain metastases (BM) may be combined with stereotactic radiosurgery (SRS) to optimize survival. We assessed patient outcomes after SRS for NSCLC BMs, identifying survival trajectories associated with targetable mutations. Methods In this retrospective cross-sectional analysis, we reviewed patient charts from 20...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2986444f-db96-57b2-a5fc-9c363b5fdf65
- DOI
- 10.21203/rs.3.rs-4254056/v1
